Search details
1.
Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarction.
Am Heart J
; 259: 79-86, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36796572
2.
Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarction.
Am J Physiol Heart Circ Physiol
; 323(4): H818-H824, 2022 10 01.
Article
in English
| MEDLINE | ID: mdl-36083798
3.
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
Am Heart J
; 241: 38-49, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34224684
4.
Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
Catheter Cardiovasc Interv
; 97(6): 1109-1117, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-32294799
5.
NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
Circ Res
; 124(5): 769-778, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30602360
6.
Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.
Eur Heart J
; 41(36): 3451-3458, 2020 09 21.
Article
in English
| MEDLINE | ID: mdl-32749459
7.
Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction.
Am Heart J
; 220: 155-175, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31821904
8.
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Circ Res
; 122(3): 479-488, 2018 02 02.
Article
in English
| MEDLINE | ID: mdl-29208679
9.
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).
Circ Res
; 122(12): 1703-1715, 2018 06 08.
Article
in English
| MEDLINE | ID: mdl-29703749
10.
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1ß- and IL-6-Related Impairment of Bone Marrow Function.
Circ Res
; 120(12): 1947-1957, 2017 Jun 09.
Article
in English
| MEDLINE | ID: mdl-28490433
11.
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.
Eur Heart J
; 39(23): 2208-2216, 2018 06 14.
Article
in English
| MEDLINE | ID: mdl-29315376
12.
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
Circulation
; 135(15): 1417-1428, 2017 Apr 11.
Article
in English
| MEDLINE | ID: mdl-28209728
13.
The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design.
Am Heart J
; 201: 141-148, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29803986
14.
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.
Am Heart J
; 201: 54-62, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29910056
15.
Revascularization in "no option" patients with refractory angina: Frequency, etiology and outcomes.
Catheter Cardiovasc Interv
; 92(7): 1215-1219, 2018 12 01.
Article
in English
| MEDLINE | ID: mdl-30079551
16.
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.
Basic Res Cardiol
; 112(1): 3, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27882430
17.
The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
Catheter Cardiovasc Interv
; 89(2): 169-177, 2017 Feb 01.
Article
in English
| MEDLINE | ID: mdl-27148802
18.
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.
Circ Res
; 117(6): 576-84, 2015 Aug 28.
Article
in English
| MEDLINE | ID: mdl-26148930
19.
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Circ Res
; 116(1): 99-107, 2015 Jan 02.
Article
in English
| MEDLINE | ID: mdl-25406300
20.
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.
Circ Res
; 116(8): 1346-60, 2015 Apr 10.
Article
in English
| MEDLINE | ID: mdl-25700037